INFRAFRONTIER Sparks Interest Among RE(ACT) 2023 Attendees

March 20, 2023


RE(ACT) Congress 2023

RE(ACT) 2023, the international congress on rare and orphan diseases co-organised by the Blackswan Foundation, IRDiRC, and the European EJP-RD programme, was held in Berlin from 15th to 18th of March.

INFRAFRONTIER attended the event with a booth and a poster, which attracted the attention of many attendees with very different professional profiles. The main message to be conveyed was the potential that the infrastructure has with its resources and services to support research on rare diseases. Proof of this is that of the approximately 8,700 lines that EMMA currently has on the archive, more than a quarter, some 2,200, carry mutations in genes related to rare diseases. Model generation and phenotyping services have also been highlighted.

The face-to-face event, which has been postponed for 3 years, was very well received, with 180 people registered and 90% attendance. One of the keys to the success of this meeting was how well the topics are linked together despite the wide range they cover. From gene and cell therapy to new technologies that facilitate the daily activities of patients or alleviate discomfort, to the laws that regulate the commercialisation of a particular therapy.

Colleagues from the German Mouse Clinic in Munich also attended with their work. It was a pleasure to spend a few days with them in such an inspiring atmosphere.

See you next year with the re(act) community, the RAREvolutionaries.

More information:

INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).